Long-Term Follow-up of Patients Treated With Miltenyi Cell and Gene Therapies
The goal of this Long-Term Follow-Up Trial is to assess long-term safety and efficacy of Miltenyi CAR T treatment.
Trial Details
- NCT ID
- NCT06508775
- Phase
- NA
- Sponsor
- Miltenyi Biomedicine GmbH
- Status
- RECRUITING
- Cancer Type
- Melanoma
- Interventions
- MB-CART19.1
- MB-CART20.1
- MB-CART2019.1
- Locations (sample)
- Berlin, Germany|52.52437,13.41053
- Cologne, Germany|50.93333,6.95
- Erlangen, Germany|49.59099,11.00783
- Göttingen, Germany|51.53443,9.93228
- Münster, Germany|51.96236,7.62571
Key Eligibility Criteria
- Patient underwent treatment with a Miltenyi CAR T cell therapy in one of the parent trials at least 12 months prior to enrollment in long-term foll…
- Patient has provided informed consent prior to enrollment.
For full eligibility, visit ClinicalTrials.gov.
Check If You May Be Eligible
Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.
Find Melanoma Trials on Trialify →